53 patents currently held
1,374 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8 more records may belong here and await a decision; they are not counted.
The next term ends in Jul 2027. from the record
Of the 1,374 now held by other companies, 636 are held via Roche Diagnostics Operations Inc., and 738 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
5
Ending by 2030
Jul 2027
Next term end
52
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2032 · High confidence
Also notable
Ends Nov 2033 · High confidence
Also notable
Ends Jul 2030 · High confidence
Laboratory Sample Distribution System, Laboratory System and Method of Operating
US 10,031,150
Cited by 47 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Laboratory Sample Distribution System and Corresponding Method of Operation
US 10,450,151
Cited by 48 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2033.
Set of Oligonucleotide Probes as Well as Methods and Uses Thereto
US 8,445,206
Cited by 50 later US patents, top 25% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Formerly held, still cited
Notable
Ends Nov 2027 · High confidence
Cited by 251 later US patents, top 5% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
held via Roche Diagnostics Operations Inc. - now held by Roche Diabetes Care, Inc.
Also notable
Ends Aug 2027 · High confidence
Cited by 204 later US patents, top 5% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
held via Roche Diagnostics Operations Inc. - now held by Roche Diabetes Care, Inc.
Also notable
Ends Jun 2031 · High confidence
Cited by 174 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
held via Roche Diagnostics Operations Inc. - now held by Roche Diabetes Care, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 25, 2026The maintenance fee for Cartridge for Dispensing a Fluid (US 10,330,693) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
- 1 fee due Jan 16, 2027The maintenance fee for Method of Operating a Laboratory Sample Distribution System, Laboratory Sample Distribution System and a Laboratory Automation System (US 10,352,953) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.
- 1 fee due Feb 28, 2027The maintenance fee for Bispecific ANTI-CCL2 Antibodies (US 11,739,142) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
- 1 fee due Mar 26, 2027The maintenance fee for Method for in Vitro Glycoengineering of Antibodies (US 11,767,342) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
- 2 fees due Apr 22, 2027
- 1 fee due Aug 13, 2027The maintenance fee for Multiple Instance Learner for Prognostic Tissue Pattern Identification (US 11,901,077) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
- 1 fee due Sep 17, 2027The maintenance fee for Oscillator, Transmission/Reception Device for a Bus System and Method for Generating a Clock Frequency Using the Oscillator (US 10,594,509) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
Recent changes
- Nov 12Assignment recorded on 1 record: Steck, Alexander to Roche Diagnostics GmbH Recorded Nov 12, 2026, executed Nov 7, 2023. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76734, frame 339.
- Oct 21Assignment recorded on 1 record: Roche Diagnostics GmbH to Roche Diagnostics Operations, Inc. Recorded Oct 21, 2026, executed Dec 5, 2024. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76455, frame 514.
- 24 of the patents on this record were granted since Aug 16, 2026
- 17 terms have ended since Aug 16, 2026
What they patent
The 5 largest of its 52 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Laboratory Sample Distribution System, Laboratory System and Method of Operating | 2 in force | to Nov 2032 |
| Linearity Control Compositions and Methods of Use | 1 in force | to Aug 2043 |
| A Method for Providing Decision Support in Relation to a Patient Receiving Oxygen Treatment | 1 in force | to Apr 2043 |
| Method and Device for Checking Pipette Tips | 1 in force | to Oct 2042 |
| System and Method for Separating an Aqueous Liquid into at Least Two Cavities | 1 in force | to Aug 2041 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,604,935 | Soluble Rubella E1 Envelope Protein Variants In force · High confidence | In force | High confidence | |
| US 9,574,186 | Stabilization of Thermolysin in Aqueous Solution In force · High confidence | In force | High confidence | |
| US 9,017,610 | Method of Determining a Complete Blood Count and a White Blood Cell Differential Count In force · Medium confidence | In force | Medium confidence | |
| US 7,975,358 | Apparatus and Method for Attaching a Drive System and a Stand to a Ring in a Medicine Gantry In force · High confidence | In force | High confidence | |
| US 8,445,206 | Set of Oligonucleotide Probes as Well as Methods and Uses Thereto In force · High confidence | In force | High confidence | |
| US 11,635,438 | IL-6 Detection Based Early Diagnosis and Prediction of Systemic Inflammatory Response Syndrome and Sepsis in Asymptomatic Patients held by Medizinische Universität Graz In force · High confidence | In force | High confidence | |
| US 9,956,559 | Instrument and Method for the Automated Thermal Treatment of Liquid Samples In force · High confidence | In force | High confidence | |
| US 8,922,761 | Measuring Volume and Constituents of Cells In force · Medium confidence | In force | Medium confidence | |
| US 8,964,171 | Identifying and Measuring Reticulocytes In force · High confidence | In force | High confidence | |
| US 9,575,086 | Laboratory Sample Distribution System, Laboratory System and Method of Operating In force · High confidence | In force | High confidence |
Also on record, not counted in the 53: 1,374 patents in force now held by others · 785 patents ended · 356 applications pending · 653 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.